glp-1 and ulcerative colitis Role of glucagon-like peptides in inflammatory bowel diseases—current knowledge future perspectives | Naunyn-Schmiedeberg's Archives of Pharmacology Frontiers | GLP-1 and GLP-2

Clinical studies show comparable effectiveness in blood sugar control and weight loss between daily oral and weekly injectable semaglutide when doses are optimized

The reduced food intake with amycretin administration is presumably driven by the direct action of amycretin in brain regions such as the hypothalamus and the hindbrain

GLP-1RAs caused gastrointestinal adverse reactions of drug withdrawal: a system review and network meta-analysis

By activating GLP-1 receptors, it stimulates insulin secretion from pancreatic beta cells, leading to better glucose utilization and reduced blood sugar levels

A., & Tosti, A

Their impact on inflammatory skin disorders suggests a novel therapeutic avenue